Considerations in the initial management of follicular lymphoma.
作者信息
Nastoupil Loretta, Sinha Rajni, Hirschey Auldyn, Flowers Christopher R
机构信息
Winship Cancer Institute, Emory University, Atlanta, GA.
出版信息
Community Oncol. 2012 Nov 1;9(11):S53-S60. doi: 10.1016/j.cmonc.2012.09.015.
Abstract
摘要
相似文献
1
Considerations in the initial management of follicular lymphoma.滤泡性淋巴瘤初始管理中的注意事项。
Community Oncol. 2012 Nov 1;9(11):S53-S60. doi: 10.1016/j.cmonc.2012.09.015.
2
Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach.滤泡性淋巴瘤：初始治疗方法中的诊断和预后考虑因素。
Curr Oncol Rep. 2019 May 23;21(7):63. doi: 10.1007/s11912-019-0808-0.
3
Primary duodenal follicular lymphoma with late disseminated nodal relapse responsive to rituximab monotherapy: A case report.原发性十二指肠滤泡性淋巴瘤伴晚期播散性淋巴结复发，对利妥昔单抗单药治疗敏感：病例报告
Mol Clin Oncol. 2017 Nov;7(5):911-914. doi: 10.3892/mco.2017.1388. Epub 2017 Aug 23.
4
Small Bowel Obstruction as an Initial Presentation of Mesenteric Follicular Lymphoma: Case Report and Literature Review.小肠梗阻作为肠系膜滤泡性淋巴瘤的首发表现：病例报告及文献综述
Cureus. 2022 Jan 24;14(1):e21566. doi: 10.7759/cureus.21566. eCollection 2022 Jan.
5
Management of patients with follicular lymphoma treated first line with obinutuzumab.
Asia Pac J Clin Oncol. 2019 May;15 Suppl 3:3-11. doi: 10.1111/ajco.13153.
6
[Anatomo-clinical considerations on follicular lymphoblastoma or Brill-Symmers disease. Case report].
G Med Mil. 1960 Jan-Feb;110:31-8.
7
What is the optimal management of early-stage low-grade follicular lymphoma in the modern era?现代早期低级别滤泡性淋巴瘤的最佳治疗方案是什么？
Cancer. 2015 Sep 15;121(18):3325-34. doi: 10.1002/cncr.29491. Epub 2015 Jun 4.
8
Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy.原发性肠道滤泡淋巴瘤患者采用观望策略的长期结果。
Sci Rep. 2023 Apr 11;13(1):5858. doi: 10.1038/s41598-023-32736-9.
9
Management of untreated advanced stage follicular lymphoma: Role of patient discernment.未经治疗的晚期滤泡性淋巴瘤的管理：患者辨别力的作用。
Best Pract Res Clin Haematol. 2018 Mar;31(1):23-30. doi: 10.1016/j.beha.2017.10.004. Epub 2017 Nov 1.
10
Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphoma.滤泡性淋巴瘤：滤泡性淋巴瘤的无化疗一线治疗。
Curr Treat Options Oncol. 2015 Jul;16(7):32. doi: 10.1007/s11864-015-0351-7.
引用本文的文献
1
Quality of Life Evaluation in Patients with Follicular Cell Lymphoma: A Real-World Study in Europe and the United States.滤泡细胞淋巴瘤患者的生活质量评估：欧洲和美国的真实世界研究。
Adv Ther. 2024 Aug;41(8):3342-3361. doi: 10.1007/s12325-024-02882-1. Epub 2024 Jul 8.
2
Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Italian Patients with Advanced Follicular Lymphoma at Intermediate-High Risk: A Cost-Effectiveness Analysis.在既往未经治疗的意大利中高危晚期滤泡性淋巴瘤患者中，奥比妥珠单抗联合化疗与利妥昔单抗联合化疗的成本效益分析
Clinicoecon Outcomes Res. 2021 Jul 22;13:661-671. doi: 10.2147/CEOR.S317885. eCollection 2021.
3
Follicular Lymphoma: Past, Present, and Future.滤泡性淋巴瘤：过去、现在与未来。
Curr Treat Options Oncol. 2018 May 24;19(7):32. doi: 10.1007/s11864-018-0550-0.
本文引用的文献
1
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi.R-CVP 对比 R-CHOP 对比 R-FM 用于晚期滤泡淋巴瘤患者的初始治疗：意大利淋巴瘤基金会 FOLL05 试验的结果。
J Clin Oncol. 2013 Apr 20;31(12):1506-13. doi: 10.1200/JCO.2012.45.0866. Epub 2013 Mar 25.
2
Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices.在国家淋巴瘤护理研究（NLCS）中检查滤泡性淋巴瘤国际预后指数（FLIPI）：一个主要在社区实践中治疗的美国前瞻性患者队列。
Ann Oncol. 2013 Feb;24(2):441-448. doi: 10.1093/annonc/mds429. Epub 2012 Oct 5.
3
Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study.一线治疗策略对 I 期滤泡性淋巴瘤的疗效：国家淋巴关爱研究分析。
J Clin Oncol. 2012 Sep 20;30(27):3368-75. doi: 10.1200/JCO.2011.40.6546. Epub 2012 Aug 20.
4
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up.利妥昔单抗诱导免疫治疗一线低肿瘤负荷滤泡淋巴瘤：7 年随访生存分析。
Ann Oncol. 2012 Sep;23(9):2380-2385. doi: 10.1093/annonc/mds177. Epub 2012 Jul 10.
5
Has the time to come leave the "watch-and-wait" strategy in newly diagnosed asymptomatic follicular lymphoma patients?新诊断无症状滤泡性淋巴瘤患者是否已到采用“观察等待”策略的时候了？
BMC Cancer. 2012 May 31;12:210. doi: 10.1186/1471-2407-12-210.
6
Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants.诱导治疗后正电子发射断层扫描-计算机断层扫描（PET-CT）对滤泡性淋巴瘤患者的预后具有高度预测性：PRIMA 试验参与者亚组的 PET-CT 分析。
J Clin Oncol. 2011 Aug 10;29(23):3194-200. doi: 10.1200/JCO.2011.35.0736. Epub 2011 Jul 11.
7
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.利妥昔单抗维持治疗对利妥昔单抗联合化疗后高肿瘤负荷滤泡性淋巴瘤患者的影响（PRIMA）：一项 3 期随机对照试验。
Lancet. 2011 Jan 1;377(9759):42-51. doi: 10.1016/S0140-6736(10)62175-7. Epub 2010 Dec 20.
8
A decade of progress in lymphoma: advances and continuing challenges.淋巴瘤研究进展十年：成就与持续挑战。
Clin Lymphoma Myeloma Leuk. 2010 Dec;10(6):414-23. doi: 10.3816/CLML.2010.n.086.
9
Reassessing the standard of care in indolent lymphoma: a clinical update to improve clinical practice.重新评估惰性淋巴瘤的治疗标准：改善临床实践的临床更新。
J Natl Compr Canc Netw. 2010 Sep;8 Suppl 6:S1-14; quiz S15. doi: 10.6004/jnccn.2010.0129.
10
Fine-needle aspiration cytology diagnosis of non-Hodgkins lymphoma in a resource-challenged environment.资源受限环境下非霍奇金淋巴瘤的细针穿刺细胞学诊断
Diagn Cytopathol. 2011 Jun;39(6):461-7. doi: 10.1002/dc.21447. Epub 2010 Sep 20.
Zotero 插件